Unlikely to cause harm — often a labeling or packaging issue.
Failed Release Testing: Out of specification for particulate matter test.
| Brand name | XELPROS |
| Generic name | LATANOPROST |
| Active ingredient(s) | LATANOPROST |
| Distributed by / for | SUN PHARMACEUTICAL INDUSTRIES INC |
| NDC | 47335-317-90 |
| Full product label | Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90 |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC |
| Distribution | TX, PA |
| Quantity | 35,069 bottles |
| Recall initiated | 2024-04-22 |
| Report date | 2024-05-29 |
| Recall completed | — |
| Recall number | D-0502-2024 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗